Antagonising the expression of VEGF in pathological angiogenesis
- 1 December 1998
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 8 (12) , 1695-1706
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- Vascular endothelial growth factor B, a novel growth factor for endothelial cells.Proceedings of the National Academy of Sciences, 1996
- Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor HeterodimerJournal of Biological Chemistry, 1995
- The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.Molecular Biology of the Cell, 1993
- Identification and Localization of Alternately Spliced mRNAs for Vascular Endothelial Growth Factor in Human Uterus and Estrogen Regulation in Endometrial Carcinoma Cell Lines1Biology of Reproduction, 1993
- Glycosylation of vascular endothelial growth factor is not required for its mitogenic activityBiochemical and Biophysical Research Communications, 1992
- The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Alternative Splicing of RNAMolecular Endocrinology, 1991
- Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.Proceedings of the National Academy of Sciences, 1990
- Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.Proceedings of the National Academy of Sciences, 1989
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983